News Releases

 
NYSE Euronext Announces Trading Volumes for April 2012
Global Derivatives ADV in April Down 7% Year-over-Year; Up 9% from 1Q12 Levels
#1 in U.S. Equity Options in April; Record Monthly Market Share for NYSE Amex Options
April European Cash ADV Up 23% and U.S. Cash ADV Down 13% Year-over-Year

     

May 8, 2012 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for April 2012[1].   Trading volumes were mixed both year-over-year and month-over-month across most venues, but reflected some strengthening relative to weak first quarter 2012 levels.  Global derivatives average daily volume (“ADV”) of 8.2 million contracts in April 2012 decreased 6.9% versus the prior year, but increased 1.4% from March 2012 and increased 9.0% from first quarter 2012 levels.  European cash trading ADV in April increased 22.8% versus the prior year, increased 14.8% from March 2012 levels and increased 17.8% from first quarter 2012 levels.  U.S. cash trading ADV decreased 13.3% and 2.5% from April 2011 and March 2012 levels, respectively, and declined 3.6% from first quarter 2012 levels.

Highlights 

  • NYSE Euronext global derivatives ADV in April 2012 of 8.2 million contracts decreased 6.9% compared to April 2011, but increased 1.4% from March 2012 levels and were up 9.0% from first quarter 2012 levels. 

  • NYSE Euronext European derivatives products ADV in April 2012 of 4.3 million contracts decreased 9.6% compared to April 2011, but increased 9.1% from March 2012 and were up 28.2% from first quarter 2012 levels.   Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.8% compared to April 2011, were in-line with March 2012 and increased 5.3% from first quarter 2012 levels. 

  • NYSE Euronext U.S. equity options ADV of 3.9 million contracts in April 2012 decreased 3.3% compared to April 2011 levels, decreased 4.9% from March 2012 and decreased 5.5% from first quarter 2012 levels.   NYSE Euronext’s U.S. options exchanges accounted for 26.4% of total U.S. consolidated equity options trading in April 2012, up from 25.7% in April 2011 and up from 26.0% in March 2012.   NYSE Euronext was the #1 U.S. equity options exchange operator in April 2012 and NYSE Amex Options recorded record monthly market share of 15.8%. 

  • NYSE Liffe U.S. ADV of approximately 61,500 contracts decreased from 91,700 contracts in April 2011 and decreased from 104,900 contracts in March 2012.

  • NYSE Euronext European cash products ADV of 1.9 million transactions in April 2012 increased 22.8% compared to April 2011 and increased 14.8% from March 2012 levels.   European cash products ADV in April 2012 was 17.8% above first quarter 2012 levels.    

  • NYSE Euronext U.S. cash products handled ADV of 1.7 billion shares in April 2012 decreased 13.3% compared to April 2011 and decreased 2.5% compared to March 2012.   U.S. cash products handled ADV in April 2012 was 3.6% below first quarter 2012 levels.  NYSE Euronext’s Tape A matched market share in April 2012 was 31.3%, down from 33.3% in April 2011, in-line with March 2012 and above the 30.6% recorded in the first quarter of 2012. 

  • There were a total of 19 trading days in Europe and 20 trading days in the U.S. in April 2012 and April 2011.

Derivatives Trading
European Derivatives  

  • NYSE Euronext European derivatives products ADV in April 2012 of 4.3 million contracts decreased 9.6% compared to April 2011, but increased 9.1% from March 2012 levels and was up 28.2% from first quarter 2012 levels. 

  • The 4.3 million in European derivatives futures and options contracts ADV in April 2012 consisted of 2.8 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.5 million contracts, or 34.4%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.  Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.8% compared to April 2011, were in-line with March 2012 and increased 5.3% from first quarter 2012 levels.

  • Year-to-date, European derivatives products ADV of 3.5 million contracts was 23.8% below prior year levels.   The 3.5 million in futures and options contracts ADV year-to-date consisted of 2.7 million contracts executed through LIFFE CONNECT trading platform and 0.8 million contracts, or 24.1%, executed through Bclear.

  • Total fixed income products ADV of 1.8 million contracts in April 2012 decreased 7.1% from April 2011, decreased 4.5% from March 2012, but were 1.0% above first quarter 2012 levels.   Year-to-date, total fixed income products ADV of 1.8 million contracts was 29.5% below prior year levels. 

  • Total equity products (including Bclear) ADV of 2.4 million contracts in April 2012 decreased 11.7% compared to April 2011, but increased 22.6% from March 2012.   The 2.4 million contracts in equity products ADV consisted of 1.8 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV.   The 2.4 million contracts in individual equity products ADV consisted of 1.3 million in futures contracts, which represented a 24.6% decrease compared to April 2011 and 0.5 million in options contracts, which represented a 4.8% increase compared to April 2011.  The average net rate per contract for individual equity futures contracts is significantly lower than other European derivatives products.  Year-to-date, total equity products ADV of 1.7 million contracts was 17.6% below prior year levels. 

  • Total commodities products ADV of approximately 81,000 contracts in April 2012 increased 4.7% compared to April 2011 and decreased 1.2% compared to March 2012.   Year-to-date, total commodities product ADV of 81,000 contracts was 4.9% below prior year levels.   

U.S. Derivatives

  • NYSE Euronext U.S. equity options ADV of 3.9 million contracts in April 2012 decreased 3.3% compared to April 2011, decreased 4.9% compared to March 2012 and were 5.5% below first quarter 2012 levels.   Year-to-date, U.S. equity options ADV of 4.1 million contracts was 5.7% below prior year levels.   

  • Total U.S. consolidated equity options ADV decreased 5.9% to 14.8 million contracts in April 2012 compared to April 2011 and decreased 6.6% compared to March 2012.   Year-to-date, U.S. consolidated equity options ADV of 15.6 million contracts was 7.7% below prior year levels.    

  • NYSE Euronext’s U.S. options exchanges accounted for 26.4% of the total U.S. consolidated equity options trading in April 2012, up from 25.7% in April 2011 and up from 26.0% in March 2012.    NYSE Euronext was the #1 U.S. equity options exchange operator in April 2012 and NYSE Amex Options recorded record monthly market share of 15.8%.

  • NYSE Liffe U.S. ADV of approximately 61,500 contracts decreased from 91,700 contracts in April 2011 and decreased from 104,900 contracts in March 2012.   Year-to-date, U.S. futures and futures options ADV of 87,700 contracts was 131.7% above prior year levels.

Cash Trading
European Cash

  • NYSE Euronext European cash products ADV of 1.9 million transactions in April 2012 increased 22.8% compared to April 2011, increased 14.8% compared to March 2012 and was 17.8% above first quarter 2012 levels. 

  • Year-to-date, European cash products ADV of 1.6 million transactions was 5.2% below prior year levels.

U.S. Cash

  • NYSE Euronext U.S. cash products handled ADV in April 2012 decreased 13.3% to 1.7 billion shares compared to April 2011, decreased 2.5% from March 2012 and was 3.6% below first quarter 2012 levels.

  • Year-to-date, U.S. cash products handled ADV was 1.8 billion shares, down 20.7% from prior year levels.     

  • NYSE Euronext’s Tape A matched market share in April 2012 was 31.3%, down from 33.3% in April 2011, in-line with March 2012 and above the 30.6% recorded in the first quarter of 2012.

Exchange Traded Funds

  • NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 216 million shares in April 2012 decreased 10.6% compared to April 2011, decreased 2.7% compared to March 2012 and decreased 2.3% compared to the first quarter of 2012. 

  • Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 220 million shares was 19.4% below prior year levels.      

Please click here for the Monthly Transaction Activity Data Table.

 

About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets — the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca — represent one-third of the worlds equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: www.nyx.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.



[1]  All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.  NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction. 



Contact: Eric Ryan
Phone: 212.656.2411
Email:  eryan@nyx.com